Murine β-defensin 2 promotes TLR-4/MyD88-mediated and NF-κB-dependent atypical death of APCs via activation of TNFR2

被引:53
作者
Biragyn, Arya [1 ]
Coscia, Marta [4 ]
Nagashima, Kunio [2 ]
Sanford, Michael [3 ]
Young, Howard A. [3 ]
Olkhanud, Purevdorj [1 ]
机构
[1] NIA, Immunol Lab, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA
[2] Sci Applicat Int Corp Frederick Inc, Frederick, MD USA
[3] NCI, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21701 USA
[4] Univ Turin, CeRMS, Azienda Osped San Giovanni Battista, Div Ematol,Lab Ematol Oncol, Turin, Italy
关键词
antimicrobial peptide; DC maturation; immunomodulation;
D O I
10.1189/jlb.1007700
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mammalian antimicrobial peptides, including beta-defensins, represent an ancient arm of innate immunity designed to directly neutralize invading microbes. Previously, we demonstrated that murine beta-defensin 2 (mDF2 beta) also acted as an endogenous ligand for TLR-4-activating maturation of dendritic cells (DCs). Herein, we report that this TLR-4-dependent activation leads to induction of an atypical cell death that is unexpectedly exaggerated by the inhibition of caspases. Experiments using APCs with nonfunctional TNF-alpha or its receptors suggest that this is a NF-kappa B- and TNF-alpha-dependent process that does not require TNFR1. We demonstrate that mDF2 beta triggers a TNFR2-mediated signaling cascade of "self-destruction" through up-regulation of membrane-bound TNF-alpha and TNFR2. This appears not to be an isolated phenomenon, as human synthetic beta-defenisn 3 was also able to activate and kill DCs. We propose that beta-defenins may play an important immunoregulatory role as controllers of the natural process of elimination of activated APCs.
引用
收藏
页码:998 / 1008
页数:11
相关论文
共 52 条
  • [1] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [2] The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Criollo, Alfredo
    Ortiz, Carla
    Lidereau, Rosette
    Mariette, Christophe
    Chaput, Nathalie
    Mira, Jean-Paul
    Delaloge, Suzette
    Andre, Fabrice
    Tursz, Thomas
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. IMMUNOLOGICAL REVIEWS, 2007, 220 : 47 - 59
  • [3] Befus AD, 1999, J IMMUNOL, V163, P947
  • [4] Defensins - Non-antibiotic use for vaccine development
    Biragyn, A
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2005, 6 (01) : 53 - 60
  • [5] Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2
    Biragyn, A
    Ruffini, PA
    Leifer, CA
    Klyushnenkova, E
    Shakhov, A
    Chertov, O
    Shirakawa, AK
    Farber, JM
    Segal, DM
    Oppenheim, JJ
    Kwak, LW
    [J]. SCIENCE, 2002, 298 (5595) : 1025 - 1029
  • [6] Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity
    Biragyn, A
    Tani, K
    Grimm, MC
    Weeks, S
    Kwak, LW
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (03) : 253 - 258
  • [7] Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens
    Biragyn, A
    Surenhu, M
    Yang, D
    Ruffini, PA
    Haines, BA
    Klyushnenkova, E
    Oppenheim, JJ
    Kwak, LW
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (11) : 6644 - 6653
  • [8] BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303
  • [9] Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2
    Cauwels, A
    Janssen, B
    Waeytens, A
    Cuvelier, C
    Brouckaert, P
    [J]. NATURE IMMUNOLOGY, 2003, 4 (04) : 387 - 393
  • [10] Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257